Therefore, we investigated the prognostic and clinical significance of histological subclassification of diffuse large B-cell NHL in a uniformly treated series of patients. For this retrospective study, all patients diagnosed as having an immunoblastic (IB) B-cell NHL by the Lymphoma Review Panel of...
DiffuseLargeB-CellLymphoma Overview Lymphomaisthemostcommonbloodcancer.Thetwomainforms oflymphomaareHodgkinlymphomaandnon-Hodgkinlymphoma (NHL).Lymphomaoccurswhencellsoftheimmunesystem calledlymphocytes,atypeofwhitebloodcell,growandmultiply uncontrollably.Cancerouslymphocytescantraveltomanypartsof ...
Diffuse large B-cell NHL (DLBCL) is a common NHL subtype in the elderly, with poorer prognosis than in younger patients. Therapy in the older and/or frail population is complicatedby comorbidities, as well as pre-existent alterations in functional status. Because of these issues as well as ...
The B-cell lymphoma 6 (BCL6) oncogene is required for the survival of diffuse large B-cell lymphoma (DLBCL), which is incurable using conventional chemotherapy. Thus, it is imperative to improve the survival of patients with DLBCL. Disulfide (DSF) has be
Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of lymphoma, which accounts for approximately 40% of non-Hodgkin lymphoma (NHL) [1]. The most common standard first-line treatment remains R-CHOP regimens, mostly rituximab plus chemotherapy (cyclophosphamide, doxorubicin, vincristine...
Rosanna Ciancia,Umberto Tirelli,Josep-Maria Ribera,Michele Spina.  Management Of Elderly Patients With Diffuse Large B-Cell Lymphomas[J]. Anti-Cancer Agents in Medicinal Chemistry . 2013 (9)Ciancia,R.,Tirelli,U.,Ribera,J.-M.,Spina,M.. Management of elderly patients with diffuse large B-...
Yunying Zhu1,2†, Chenshuang Lei1,2†, Qian Jiang1,2†, Qinhua Yu2 and Liannv Qiu2* Abstract Background: The B-cell lymphoma 6 (BCL6) oncogene is required for the survival of diffuse large B-cell lymphoma (DLBCL), which is incurable using conventional ...
Diffuse Large B-cell Lymphomas (DLBCL) are the most frequent Non-Hodgkin Lymphomas (NHL). The addition of Rituximab to the standard chemotherapy CHOP improved the outcome in this patients, but so far 40% of patients experienced relapse or progressive disease. Lenalidomide, an immunomodulatory agent...
Diffuse large B-cell lymphoma GCB-like DLBCL: Germinal center B-cell-like DLBCL ABC-like DLBCL: Activated B-cell-like DLBCL JCPyV: JC Polyomavirus VLPs: Virus-like particles TK: Thymidine kinase GCV: Ganciclovir B-NHL: B-cell non-Hodgkin lymphoma MDR: Multidrug resistance HSV:...
弥漫性大B细胞淋巴瘤 1. Prognosis of R-CHOP regimen in treatment of young adult patients with diffuse large B-cell lymphoma; R-CHOP方案治疗年轻弥漫性大B细胞淋巴瘤患者预后分析 2. Progress in the diagnosis and treatment of diffuse large B-cell lymphoma; 弥漫性大B细胞淋巴瘤诊治进展 更多例句...